Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2005
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233991 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
10/20/2005US20050233983 Treatment of rumen acidosis with alpha-amylase inhibitors
10/20/2005US20050233969 Analogues of GLP-1
10/20/2005US20050233955 Stimulation of nerve cell regeneration
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005US20050233455 Acyclic linker-containing oligonucleotides and uses thereof
10/20/2005US20050233417 Growth hormone variations in humans and their uses
10/20/2005US20050233396 an assay method of infecting cultured cells with vaccinia virus;co-transfecting the cells with plasmids of DNA encoding the I7L protease enzyme such that both the substrate protein and enzyme are expressed; then measuring cleaved I7L protease
10/20/2005US20050233385 Using antibodies on cell surfaces
10/20/2005US20050233361 PPARdelta assay
10/20/2005US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor
10/20/2005US20050233326 Drug screening for binding property or signal transduction between a G protein-coupled receptor and humanin or a salt; Alzheimer*s disease
10/20/2005US20050233012 Hair growth stimulants for oral use
10/20/2005US20050232998 Dry powder inhalant composition
10/20/2005US20050232916 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
10/20/2005US20050232915 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
10/20/2005US20050232903 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure
10/20/2005US20050232899 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
10/20/2005US20050232870 Method of treatment of dopamine-related dysfunction
10/20/2005US20050232862 Combination therapy for the treatment of estrogen-sensitive drugs
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2561947A1 Preventives/remedies for cancer
10/20/2005CA2561164A1 Steroid sparing agents and their use
10/20/2005CA2560131A1 Compounds for treating proliferative processes
10/19/2005EP1586582A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2005EP1586572A1 Fused pyrazolyls as anti-cancer drugs
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586561A1 Bicyclic aromatic sulfinyl derivatives
10/19/2005EP1586560A1 Thio-substituted arylmethanesulfinyl derivatives
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1586328A1 Agent for improving life expectancy in therapy of malignant tumor
10/19/2005EP1586325A1 Drugs containing galectin 9
10/19/2005EP1586324A1 Ophthalmic therapeutic composition
10/19/2005EP1586323A1 Use of fulvestrant in the treatment of resistant breast cancer
10/19/2005EP1586321A1 New use of glutamate antagonists for the treatment of cancer
10/19/2005EP1586312A1 Agent for dissolving dental calculi and dental caries
10/19/2005EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2005EP1585955A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/19/2005EP1585509A1 Sphingolipids for improvement of the composition of the intestinal flora
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1423117B1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
10/19/2005EP1414837B1 Adenosine a3 receptor agonists
10/19/2005EP1406902B1 Hexahydroazepino[4,5-g]indoles and indolines as 5-ht receptor ligands
10/19/2005EP1401837B1 Purine derivatives as a2b adenosine receptor antagonists
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1339438B1 Preventing transplant rejection in the eye
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1307245B1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
10/19/2005EP1307186A4 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
10/19/2005EP1292340B1 Transfection system
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP1240142B1 New modulators of dopamine neurotransmission
10/19/2005EP1202993B1 Phenanthroline-7-one derivatives and their therapeutic uses
10/19/2005EP1202728B1 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins.
10/19/2005EP1173217B1 Enhanced delivery of nucleic acid-based drugs
10/19/2005EP1137635B1 N-substituted 2-cyanopyrrolidines
10/19/2005EP1102752B1 Succinoylamino lactams as inhibitors of a beta protein production
10/19/2005EP1100541B1 Hydrogel for the therapeutic treatment of aneurysms
10/19/2005EP1086071B1 Hyperforin derivatives, the use thereof and formulations containing them
10/19/2005EP1075260B1 Novel fatty acid analogues for the treatment of secondary restenosis
10/19/2005EP1041956B1 Mixture for the oxidation tinting of keratin fibres containing a laccase and tinting method using said mixture
10/19/2005EP1033998B1 Suppressing beta-amyloid-related changes in alzheimer's disease
10/19/2005EP1000163B1 Pseudomonas exotoxin a-like chimeric immunogens
10/19/2005EP0831891B1 Oxidant scavengers
10/19/2005EP0814774B1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
10/19/2005EP0793499B1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
10/19/2005CN1685055A Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
10/19/2005CN1684975A Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/19/2005CN1684966A Novel adenine compound and use thereof
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684948A Cytotoxic agents containing novel potent taxanes and their therapeutic use
10/19/2005CN1684689A Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin
10/19/2005CN1684679A Preventive or remedy for bedsore
10/19/2005CN1684675A A composition comprising phytospingosine derivatives for apoptosis induction
10/19/2005CN1684674A Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1684669A Compositions comprising HMG-CoA reductase inhibitor
10/19/2005CN1683395A Nuclear factor-K B P65 subunit antagonistic peptide and its use
10/19/2005CN1683009A Specific skin regent for diagnozing tuberculomyces infection and active tuberculosis
10/19/2005CN1682973A Cepharanthine oral disintegration tablet and its preparing method
10/19/2005CN1682877A Medicinal composition for treating cyst
10/19/2005CN1682806A Ginseng and fleece-flower root dripping pill and its preparing method
10/19/2005CN1682802A Heart and brain health dripping pill for refreshing and strengthening brain and its preparing method
10/19/2005CN1682797A Active source preparation and its rpeparing method
10/19/2005CN1682756A Supplementing method for exogenous nitric oxide
10/19/2005CN1682715A Anti-anoxia medicinal composition
10/19/2005CN1682682A Hair tension and hardness improving agent
10/19/2005CN1223672C Grifola frondosa mycelia moisture method ultra micro wall break method
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223371C Preparation of effective component from rhodiola crenulate and preparing method
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 1564